{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:14:56Z","timestamp":1793798096900,"version":"4.6.1"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82160546"],"award-info":[{"award-number":["82160546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82460116"],"award-info":[{"award-number":["82460116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science Foundation of Jiangxi Province","award":["20202BBG73027"],"award-info":[{"award-number":["20202BBG73027"]}]},{"name":"Science Foundation of Jiangxi Province","award":["20242BAB26116"],"award-info":[{"award-number":["20242BAB26116"]}]},{"name":"Foundation of Jiangxi Province for Distinguished Scholars","award":["JXSQ2023201020"],"award-info":[{"award-number":["JXSQ2023201020"]}]},{"name":"Science and Technology Plan Fund of Jiangxi Health Commission","award":["20183021"],"award-info":[{"award-number":["20183021"]}]},{"DOI":"10.13039\/501100010857","name":"Science and Technology Department of Jiangxi Province","doi-asserted-by":"crossref","award":["20202ACBL206017"],"award-info":[{"award-number":["20202ACBL206017"]}],"id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009102","name":"Education Department of Jiangxi Province","doi-asserted-by":"publisher","award":["GJJ210185"],"award-info":[{"award-number":["GJJ210185"]}],"id":[{"id":"10.13039\/501100009102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The gut microbiota plays a crucial role in safeguarding host health and driving the progression of intestinal diseases. Despite recent advances in the remarkable correlation between dysbiosis and extraintestinal cancers, the underlying mechanisms are yet to be fully elucidated. Pathogenic microbiota, along with their metabolites, can undermine the integrity of the gut barrier through inflammatory or metabolic pathways, leading to increased permeability and the translocation of pathogens. The dissemination of pathogens through the circulation may contribute to the establishment of an immune-suppressive environment that promotes carcinogenesis in extraintestinal organs either directly or indirectly. The oncogenic cascade always engages in the disruption of hormonal regulation and inflammatory responses, the induction of genomic instability and mutations, and the dysregulation of adult stem cell proliferation. This review aims to comprehensively summarize the existing evidence that points to the potential role of dysbiosis in the malignant transformation of extraintestinal organs such as the liver, breast, lung, and pancreas. Additionally, we delve into the limitations inherent in current methodologies, particularly the challenges associated with differentiating low loads gut-derived microbiome within tumors from potential sample contamination or symbiotic microorganisms. Although still controversial, an understanding of the contribution of translocated intestinal microbiota and their metabolites to the pathological continuum from chronic inflammation to tumors could offer a novel foundation for the development of targeted therapeutics.<\/jats:p>","DOI":"10.1186\/s13046-025-03313-x","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T02:15:56Z","timestamp":1738894556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Dysbiosis and extraintestinal cancers"],"prefix":"10.1186","volume":"44","author":[{"given":"Ruishan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingqian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzhen","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1596-2013","authenticated-orcid":false,"given":"Huan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"3313_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA: A Cancer J Clin. 2024;74(1):12\u201349.","DOI":"10.3322\/caac.21820"},{"issue":"1","key":"3313_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends\u2014an update. Cancer Epidemiol Biomark Prev. 2016;25(1):16\u201327.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"3313_CR3","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.3390\/ijms21093115","volume":"21","author":"MM Azevedo","year":"2020","unstructured":"Azevedo MM, Pina-Vaz C, Baltazar F. Microbes and cancer: friends or faux? Int J Mole Sci. 2020;21(9):3115.","journal-title":"Int J Mole Sci"},{"issue":"7","key":"3313_CR4","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1136\/gutjnl-2022-327952","volume":"72","author":"A Saftien","year":"2023","unstructured":"Saftien A, Puschhof J, Elinav E. Fungi and cancer. Gut. 2023;72(7):1410\u201325.","journal-title":"Gut"},{"issue":"5","key":"3313_CR5","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM de Vos","year":"2022","unstructured":"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020\u201332.","journal-title":"Gut"},{"issue":"3","key":"3313_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41385-020-00365-4","volume":"14","author":"F Malard","year":"2021","unstructured":"Malard F, Dore J, Gaugler B, Mohty M. Introduction to host microbiome symbiosis in health and disease. Mucosal Immunol. 2021;14(3):547\u201354.","journal-title":"Mucosal Immunol"},{"issue":"11","key":"3313_CR7","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1128\/AEM.65.11.4799-4807.1999","volume":"65","author":"A Suau","year":"1999","unstructured":"Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dor\u00e9 J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol. 1999;65(11):4799\u2013807.","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"3313_CR8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/CMR.00011-10","volume":"23","author":"LE Wroblewski","year":"2010","unstructured":"Wroblewski LE, Peek RM, Wilson KT. Helicobacter pyloriand gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713\u201339.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"3313_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):553\u201364.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3313_CR10","doi-asserted-by":"crossref","unstructured":"Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, Gurjao C, Manders F, Dalmasso G, et al. Mutational signature in colorectal cancer caused by genotoxic pks(+) E. coli. Nature. 2020;580(7802):269\u201373.","DOI":"10.1038\/s41586-020-2080-8"},{"issue":"3","key":"3313_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.immuni.2018.08.018","volume":"49","author":"T Wang","year":"2018","unstructured":"Wang T, Fan C, Yao A, Xu X, Zheng G, You Y, Jiang C, Zhao X, Hou Y, et al. The adaptor protein CARD9 protects against colon cancer by restricting mycobiota-mediated expansion of myeloid-derived suppressor cells. Immunity. 2018;49(3):504\u201314.e4.","journal-title":"Immunity"},{"issue":"4","key":"3313_CR12","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.cell.2020.10.040","volume":"183","author":"RAT Mars","year":"2020","unstructured":"Mars RAT, Yang Y, Ward T, Houtti M, Priya S, Lekatz HR, Tang X, Sun Z, Kalari KR, et al. Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome. Cell. 2020;183(4):1137\u201340.","journal-title":"Cell"},{"issue":"3","key":"3313_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/19490976.2017.1290757","volume":"8","author":"AR Weingarden","year":"2017","unstructured":"Weingarden AR, Vaughn BP. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes. 2017;8(3):238\u201352.","journal-title":"Gut Microbes"},{"issue":"1","key":"3313_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7150\/ijbs.37399","volume":"16","author":"S Liang","year":"2020","unstructured":"Liang S, Mao Y, Liao M, Xu Y, Chen Y, Huang X, Wei C, Wu C, Wang Q, et al. Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps. Int J Biol Sci. 2020;16(1):135\u201346.","journal-title":"Int J Biol Sci"},{"key":"3313_CR15","doi-asserted-by":"crossref","unstructured":"Liu Y, Lau HC-H, Cheng WY, Yu J. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment. Genom Proteomics Bioinform. 2023;21(1) 84\u201396.","DOI":"10.1016\/j.gpb.2022.07.002"},{"issue":"2","key":"3313_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","volume":"72","author":"RF Schwabe","year":"2020","unstructured":"Schwabe RF, Greten TF. Gut microbiome in HCC - Mechanisms, diagnosis and therapy. J Hepatol. 2020;72(2):230\u20138.","journal-title":"J Hepatol"},{"issue":"1","key":"3313_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12885-019-5660-y","volume":"19","author":"J Plaza-D\u00edaz","year":"2019","unstructured":"Plaza-D\u00edaz J, \u00c1lvarez-Mercado AI, Ruiz-Mar\u00edn CM, Reina-P\u00e9rez I, P\u00e9rez-Alonso AJ, S\u00e1nchez-Andujar MB, et al. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study. BMC Cancer. 2019;19(1):495.","journal-title":"BMC Cancer"},{"issue":"11","key":"3313_CR18","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.7150\/ijbs.35980","volume":"15","author":"F Liu","year":"2019","unstructured":"Liu F, Li J, Guan Y, Lou Y, Chen H, Xu M, Deng D, Chen J, Ni B, et al. Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer. Int J Biol Sci. 2019;15(11):2381\u201392.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"3313_CR19","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/carcin\/bgy073","volume":"39","author":"RM Thomas","year":"2018","unstructured":"Thomas RM, Gharaibeh RZ, Gauthier J, Beveridge M, Pope JL, Guijarro MV, Yu Q, He Z, Ohland C, et al. Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models. Carcinogenesis. 2018;39(8):1068\u201378.","journal-title":"Carcinogenesis"},{"issue":"1","key":"3313_CR20","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1038\/s41467-022-31312-5","volume":"13","author":"KM Schneider","year":"2022","unstructured":"Schneider KM, Mohs A, Gui W, Galvez EJC, Candels LS, Hoenicke L, et al. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment. Nat Commun. 2022;13(1):3964.","journal-title":"Nat Commun"},{"issue":"3","key":"3313_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/0008-5472.CAN-06-3468","volume":"67","author":"VP Rao","year":"2007","unstructured":"Rao VP, Poutahidis T, Fox JG, Erdman SE. Breast cancer: should gastrointestinal bacteria be on our radar screen? Cancer Res. 2007;67(3):847\u201350.","journal-title":"Cancer Res"},{"issue":"2","key":"3313_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12282-016-0734-z","volume":"24","author":"J Yang","year":"2016","unstructured":"Yang J, Tan Q, Fu Q, Zhou Y, Hu Y, Tang S, Zhou Y, Zhang J, Qiu J, et al. Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications. Breast Cancer. 2016;24(2):220\u20138.","journal-title":"Breast Cancer"},{"issue":"2","key":"3313_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/1055-9965.EPI-18-0542","volume":"28","author":"E del Castillo","year":"2019","unstructured":"del Castillo E, Meier R, Chung M, Koestler DC, Chen T, Paster BJ, Charpentier KP, Kelsey KT, Izard J, et al. The microbiomes of pancreatic and duodenum tissue overlap and are highly subject specific but differ between pancreatic cancer and noncancer subjects. Cancer Epidemiol Biomark Prev. 2019;28(2):370\u201383.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"3313_CR24","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camilleri","year":"2019","unstructured":"Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68(8):1516\u201326.","journal-title":"Gut"},{"issue":"4","key":"3313_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41579-022-00794-x","volume":"21","author":"AP Rogers","year":"2023","unstructured":"Rogers AP, Mileto SJ, Lyras D. Impact of enteric bacterial infections at and beyond the epithelial barrier. Nat Rev Microbiol. 2023;21(4):260\u201374.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"3313_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","volume":"14","author":"SC Bischoff","year":"2014","unstructured":"Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke J-D, Serino M, Tilg H, Watson A, Wells JM. Intestinal permeability \u2013 a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14(1):189.","journal-title":"BMC Gastroenterol"},{"key":"3313_CR27","doi-asserted-by":"crossref","unstructured":"Ghosh S, Yannie PJ, Wang J, Ghosh SS. Intestinal barrier dysfunction, LPS translocation, and disease development. J Endocrine Soc. 2020;4(2):bvz039.","DOI":"10.1210\/jendso\/bvz039"},{"issue":"12","key":"3313_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nri.2017.100","volume":"17","author":"I Spadoni","year":"2017","unstructured":"Spadoni I, Fornasa G, Rescigno M. Organ-specific protection mediated by cooperation between vascular and epithelial barriers. Nat Rev Immunol. 2017;17(12):761\u201373.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"3313_CR29","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","volume":"69","author":"P Paone","year":"2020","unstructured":"Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: the expected slimy partners? Gut. 2020;69(12):2232\u201343.","journal-title":"Gut"},{"key":"3313_CR30","doi-asserted-by":"crossref","unstructured":"Alam A, Neish A. Role of gut microbiota in intestinal wound healing and barrier function. Tissue Barriers. 2018;6(3):1539595.","DOI":"10.1080\/21688370.2018.1539595"},{"key":"3313_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.aninu.2021.09.012","volume":"9","author":"J Ma","year":"2022","unstructured":"Ma J, Piao X, Mahfuz S, Long S, Wang J. The interaction among gut microbes, the intestinal barrier and short chain fatty acids. Anim Nutr. 2022;9:159\u201374.","journal-title":"Anim Nutr"},{"issue":"9","key":"3313_CR32","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrm.2016.80","volume":"17","author":"C Zihni","year":"2016","unstructured":"Zihni C, Mills C, Matter K, Balda MS. Tight junctions: from simple barriers to multifunctional molecular gates. Nat Rev Mol Cell Biol. 2016;17(9):564\u201380.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"21","key":"3313_CR33","doi-asserted-by":"publisher","first-page":"R1135","DOI":"10.1016\/j.cub.2023.09.027","volume":"33","author":"MS Balda","year":"2023","unstructured":"Balda MS, Matter K. Tight junctions. Curr Biol. 2023;33(21):R1135\u201340.","journal-title":"Curr Biol"},{"issue":"6","key":"3313_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2982.2012.01921.x","volume":"24","author":"M Camilleri","year":"2012","unstructured":"Camilleri M, Madsen K, Spiller R, Van Meerveld BG, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012;24(6):503\u201312.","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"3313_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6107(02)00037-8","volume":"81","author":"L Gonz\u00e1lez-Mariscal","year":"2003","unstructured":"Gonz\u00e1lez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Prog Biophys Mol Biol. 2003;81(1):1\u201344.","journal-title":"Prog Biophys Mol Biol"},{"key":"3313_CR36","doi-asserted-by":"crossref","unstructured":"Jingjie W, Jun S. Gut vascular barrier in the pathogenesis and resolution of Crohn's disease: a novel link from origination to therapy. Clin Immunol. 2023;253:109683.","DOI":"10.1016\/j.clim.2023.109683"},{"issue":"2","key":"3313_CR37","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3390\/ijms24021470","volume":"24","author":"N Di Tommaso","year":"2023","unstructured":"Di Tommaso N, Santopaolo F, Gasbarrini A, Ponziani FR. The gut\u2013vascular barrier as a new protagonist in intestinal and extraintestinal diseases. Int J Mole Sci. 2023;24(2):1470.","journal-title":"Int J Mole Sci"},{"issue":"8370","key":"3313_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0140-6736(84)92109-3","volume":"1","author":"I Bjarnason","year":"1984","unstructured":"Bjarnason I, Peters TJ, Wise RJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet. 1984;1(8370):179\u201382.","journal-title":"Lancet"},{"key":"3313_CR39","doi-asserted-by":"crossref","unstructured":"Massier L, Bluher M, Kovacs P, Chakaroun RM. Impaired intestinal barrier and tissue bacteria: pathomechanisms for metabolic diseases. Front Endocrinol (Lausanne). 2021;12:616506.","DOI":"10.3389\/fendo.2021.616506"},{"issue":"1","key":"3313_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/nrmicro2266","volume":"8","author":"CE Bryant","year":"2010","unstructured":"Bryant CE, Spring DR, Gangloff M, Gay NJ. The molecular basis of the host response to lipopolysaccharide. Nat Rev Microbiol. 2010;8(1):8\u201314.","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"3313_CR41","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1286-4579(03)00207-7","volume":"5","author":"F B\u00e4ckhed","year":"2003","unstructured":"B\u00e4ckhed F, Normark S, Schweda EKH, Oscarson S, Richter-Dahlfors A. Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications. Microbes Infect. 2003;5(12):1057\u201363.","journal-title":"Microbes Infect"},{"key":"3313_CR42","doi-asserted-by":"crossref","unstructured":"Yang R, Hu X, Xie X, Chen H, Fang H, Zhu L, et al. Propionic acid targets the TLR4\/NF-\u03baB signaling pathway and inhibits LPS-induced intestinal barrier dysfunction: in vitro and in vivo studies. Front Pharmacol. 2020;11:573475.","DOI":"10.3389\/fphar.2020.573475"},{"issue":"2","key":"3313_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/jcp.25435","volume":"232","author":"A Bein","year":"2016","unstructured":"Bein A, Zilbershtein A, Golosovsky M, Davidov D, Schwartz B. LPS induces hyper-permeability of intestinal epithelial cells. J Cell Physiol. 2016;232(2):381\u201390.","journal-title":"J Cell Physiol"},{"issue":"1","key":"3313_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/jir.2008.0128","volume":"29","author":"MA Boivin","year":"2009","unstructured":"Boivin MA, Roy PK, Bradley A, Kennedy JC, Rihani T, Ma TY. Mechanism of interferon-\u03b3\u2013induced increase in T84 intestinal epithelial tight junction. J Interferon Cytokine Res. 2009;29(1):45\u201354.","journal-title":"J Interferon Cytokine Res"},{"issue":"3","key":"3313_CR45","doi-asserted-by":"publisher","first-page":"G422","DOI":"10.1152\/ajpgi.00412.2004","volume":"288","author":"TY Ma","year":"2005","unstructured":"Ma TY, Boivin MA, Ye D, Pedram A, Said HM. Mechanism of TNF-\u03b1 modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol. 2005;288(3):G422\u201330.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"10","key":"3313_CR46","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1242\/jcs.02915","volume":"119","author":"L Shen","year":"2006","unstructured":"Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE, Turner JR. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci. 2006;119(10):2095\u2013106.","journal-title":"J Cell Sci"},{"issue":"18","key":"3313_CR47","doi-asserted-by":"publisher","first-page":"8237","DOI":"10.1073\/pnas.0908869107","volume":"107","author":"D Yu","year":"2010","unstructured":"Yu D, Marchiando AM, Weber CR, Raleigh DR, Wang Y, Shen L, Turner JR. MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proc Natl Acad Sci. 2010;107(18):8237\u201341.","journal-title":"Proc Natl Acad Sci"},{"key":"3313_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","volume":"14","author":"SC Bischoff","year":"2014","unstructured":"Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, et al. Intestinal permeability\u2013a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"3313_CR49","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.resmic.2013.03.019","volume":"164","author":"T Tosi","year":"2013","unstructured":"Tosi T, Pflug A, Discola KF, Neves D, Dessen A. Structural basis of eukaryotic cell targeting by type III secretion system (T3SS) effectors. Res Microbiol. 2013;164(6):605\u201319.","journal-title":"Res Microbiol"},{"issue":"2","key":"3313_CR50","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/sj.icb.7100007","volume":"85","author":"B Coburn","year":"2006","unstructured":"Coburn B, Grassl GA, Finlay BB. Salmonella, the host and disease: a brief review. Immunol Cell Biol. 2006;85(2):112\u20138.","journal-title":"Immunol Cell Biol"},{"key":"3313_CR51","doi-asserted-by":"crossref","unstructured":"Fulde M, van Vorst K, Zhang K, Westermann AJ, Busche T, Huei YC, et al. SPI2 T3SS effectors facilitate enterocyte apical to basolateral transmigration of Salmonella-containing vacuoles in vivo. Gut Microbes. 2021;13(1):1973836.","DOI":"10.1080\/19490976.2021.1973836"},{"issue":"20","key":"3313_CR52","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.3390\/nu16203494","volume":"16","author":"A Matar","year":"2024","unstructured":"Matar A, Damianos JA, Jencks KJ, Camilleri M. Intestinal barrier impairment, preservation, and repair: an update. Nutrients. 2024;16(20):3494.","journal-title":"Nutrients"},{"issue":"9","key":"3313_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.earlhumdev.2006.12.002","volume":"83","author":"Z Stratiki","year":"2007","unstructured":"Stratiki Z, Costalos C, Sevastiadou S, Kastanidou O, Skouroliakou M, Giakoumatou A, Petrohilou V. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Human Dev. 2007;83(9):575\u20139.","journal-title":"Early Human Dev"},{"key":"3313_CR54","doi-asserted-by":"crossref","unstructured":"Bonfrate L, Di Palo DM, Celano G, Albert A, Vitellio P, De Angelis M, et al. Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients. Eur J Clin Invest. 2020;50(3):e13201.","DOI":"10.1111\/eci.13201"},{"issue":"3","key":"3313_CR55","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/foods11030268","volume":"11","author":"C Chaiyasut","year":"2022","unstructured":"Chaiyasut C, Sivamaruthi BS, Lailerd N, Sirilun S, Khongtan S, Fukngoen P, et al. Probiotics supplementation improves intestinal permeability, obesity index and metabolic biomarkers in elderly Thai subjects: a randomized controlled trial. Foods. 2022;11(3):268.","journal-title":"Foods"},{"key":"3313_CR56","doi-asserted-by":"crossref","unstructured":"Meena AS, Shukla PK, Bell B, Giorgianni F, Caires R, Fern\u00e1ndez-Pe\u00f1a C, et al. TRPV6 channel mediates alcohol-induced gut barrier dysfunction and systemic response. Cell Rep. 2022;39(11):110937.","DOI":"10.1016\/j.celrep.2022.110937"},{"issue":"3","key":"3313_CR57","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/hep.27489","volume":"61","author":"P Chen","year":"2015","unstructured":"Chen P, St\u00e4rkel P, Turner JR, Ho SB, Schnabl B. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology (Baltimore, MD). 2015;61(3):883\u201394.","journal-title":"Hepatology (Baltimore, MD)"},{"key":"3313_CR58","doi-asserted-by":"crossref","unstructured":"Lathakumari RH, Vajravelu LK, Satheesan A, Ravi S, Thulukanam J. Antibiotics and the gut microbiome: understanding the impact on human health. Med Microecology. 2024;20:100106.","DOI":"10.1016\/j.medmic.2024.100106"},{"key":"3313_CR59","doi-asserted-by":"crossref","unstructured":"Anthony WE, Wang B, Sukhum KV, D\u2019Souza AW, Hink T, Cass C, et al. Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults. Cell Rep. 2022;39(2):110649.","DOI":"10.1016\/j.celrep.2022.110649"},{"issue":"6","key":"3313_CR60","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1080\/10408398.2020.1843396","volume":"62","author":"H Duan","year":"2020","unstructured":"Duan H, Yu L, Tian F, Zhai Q, Fan L, Chen W. Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies. Crit Rev Food Sci Nutr. 2020;62(6):1427\u201352.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"3313_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/advances\/nmz061","volume":"11","author":"MW Rohr","year":"2020","unstructured":"Rohr MW, Narasimhulu CA, Rudeski-Rohr TA, Parthasarathy S. Negative effects of a high-fat diet on intestinal permeability: a review. Adv Nutr. 2020;11(1):77\u201391.","journal-title":"Adv Nutr"},{"issue":"4","key":"3313_CR62","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1017\/S0007114512005612","volume":"110","author":"JR Mujico","year":"2013","unstructured":"Mujico JR, Baccan GC, Gheorghe A, D\u00edaz LE, Marcos A. Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice. Br J Nutr. 2013;110(4):711\u201320.","journal-title":"Br J Nutr"},{"issue":"1","key":"3313_CR63","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1053\/j.gastro.2021.08.041","volume":"162","author":"J Yang","year":"2022","unstructured":"Yang J, Wei H, Zhou Y, Szeto C-H, Li C, Lin Y, Coker OO, Lau HCH, Chan AWH, et al. High-fat diet promotes colorectal tumorigenesis through modulating gut microbiota and metabolites. Gastroenterology. 2022;162(1):135\u201349.e2.","journal-title":"Gastroenterology"},{"issue":"1","key":"3313_CR64","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12929-021-00711-z","volume":"28","author":"X Tang","year":"2021","unstructured":"Tang X, Wang W, Hong G, Duan C, Zhu S, Tian Y, et al. Gut microbiota-mediated lysophosphatidylcholine generation promotes colitis in intestinal epithelium-specific Fut2 deficiency. J Biomed Sci. 2021;28(1):20.","journal-title":"J Biomed Sci"},{"issue":"20","key":"3313_CR65","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1016\/j.cell.2024.07.039","volume":"187","author":"N Carlino","year":"2024","unstructured":"Carlino N, Blanco-M\u00edguez A, Pun\u010doch\u00e1\u0159 M, Mengoni C, Pinto F, Tatti A, Manghi P, Armanini F, Avagliano M, et al. Unexplored microbial diversity from 2,500 food metagenomes and links with the human microbiome. Cell. 2024;187(20):5775\u201395.e15.","journal-title":"Cell"},{"issue":"1","key":"3313_CR66","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","volume":"60","author":"R Wiest","year":"2014","unstructured":"Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60(1):197\u2013209.","journal-title":"J Hepatol"},{"issue":"6","key":"3313_CR67","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1080\/19490976.2016.1239681","volume":"7","author":"I Spadoni","year":"2016","unstructured":"Spadoni I, Pietrelli A, Pesole G, Rescigno M. Gene expression profile of endothelial cells during perturbation of the gut vascular barrier. Gut Microbes. 2016;7(6):540\u20138.","journal-title":"Gut Microbes"},{"issue":"6262","key":"3313_CR68","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1126\/science.aad0135","volume":"350","author":"I Spadoni","year":"2015","unstructured":"Spadoni I, Zagato E, Bertocchi A, Paolinelli R, Hot E, Di Sabatino A, Caprioli F, Bottiglieri L, Oldani A, et al. A gut-vascular barrier controls the systemic dissemination of bacteria. Science. 2015;350(6262):830\u20134.","journal-title":"Science"},{"key":"3313_CR69","doi-asserted-by":"crossref","unstructured":"Bertocchi A, Carloni S, Ravenda PS, Bertalot G, Spadoni I, Lo Cascio A, Gandini S, Lizier M, Braga D, et al. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver. Cancer Cell. 2021;39(5):708\u201324 e11.","DOI":"10.1016\/j.ccell.2021.03.004"},{"issue":"3","key":"3313_CR70","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3748\/wjg.v28.i3.310","volume":"28","author":"L Chrysavgis","year":"2022","unstructured":"Chrysavgis L, Giannakodimos I, Diamantopoulou P, Cholongitas E. Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. World J Gastroenterol. 2022;28(3):310\u201331.","journal-title":"World J Gastroenterol"},{"key":"3313_CR71","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.lfs.2018.08.017","volume":"209","author":"C Cheng","year":"2018","unstructured":"Cheng C, Tan J, Qian W, Zhang L, Hou X. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: attention to the gut-vascular barrier dysfunction. Life Sci. 2018;209:157\u201366.","journal-title":"Life Sci"},{"key":"3313_CR72","doi-asserted-by":"crossref","unstructured":"Ponziani FR, Nicoletti A, Gasbarrini A, Pompili M. Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma. Ther Adv Med Oncol. 2019;11:1758835919848184.","DOI":"10.1177\/1758835919848184"},{"key":"3313_CR73","doi-asserted-by":"crossref","unstructured":"Wang X, Fang Y, Liang W, Cai Y, Wong CC, Wang J, Wang N, Lau HC-H, Jiao Y, et al. Gut\u2013liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in mice. Nature Microbiology, 2025;10(1):169\u201384.","DOI":"10.1038\/s41564-024-01890-9"},{"issue":"4","key":"3313_CR74","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","volume":"21","author":"DH Dapito","year":"2012","unstructured":"Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, Caviglia JM, Khiabanian H, Adeyemi A, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21(4):504\u201316.","journal-title":"Cancer Cell"},{"issue":"11","key":"3313_CR75","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki E, De Minicis S, \u00d6sterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis. Nat Med. 2007;13(11):1324\u201332.","journal-title":"Nat Med"},{"issue":"23","key":"3313_CR76","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.3748\/wjg.v18.i23.2938","volume":"18","author":"J Yang","year":"2012","unstructured":"Yang J, Zhang JX, Wang H, Wang GL, Hu QG, Zheng QC. Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling. World J Gastroenterol. 2012;18(23):2938\u201347.","journal-title":"World J Gastroenterol"},{"key":"3313_CR77","doi-asserted-by":"crossref","unstructured":"Scott EN, Gocher AM, Workman CJ, Vignali DAA. Regulatory T cells: barriers of immune infiltration into the tumor microenvironment. Front Immunol. 2021;12:702726.","DOI":"10.3389\/fimmu.2021.702726"},{"key":"3313_CR78","doi-asserted-by":"crossref","unstructured":"Tang Y-L, Zhu L, Tao Y, Lu W, Cheng H. Role of targeting TLR4 signaling axis in liver-related diseases. Pathol Res Pract. 2023;244:154410.","DOI":"10.1016\/j.prp.2023.154410"},{"key":"3313_CR79","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/JHC.S44515","volume":"2","author":"QC Zheng","year":"2015","unstructured":"Zheng QC, Yang J, Li M. Emerging role of Toll-like receptor 4 in hepatocellular carcinoma. J Hepatocell Carcinoma. 2015;2:11\u20137.","journal-title":"J Hepatocell Carcinoma"},{"issue":"6","key":"3313_CR80","first-page":"9647","volume":"15","author":"Y Kang","year":"2018","unstructured":"Kang Y, Su G, Sun J, Zhang Y. Activation of the TLR4\/MyD88 signaling pathway contributes to the development of human hepatocellular carcinoma via upregulation of IL-23 and IL-17A. Oncol Letters. 2018;15(6):9647\u201354.","journal-title":"Oncol Letters"},{"issue":"5","key":"3313_CR81","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s11033-009-9710-4","volume":"37","author":"X Liu","year":"2010","unstructured":"Liu X, Liang J, Li G. Lipopolysaccharide promotes adhesion and invasion of hepatoma cell lines HepG2 and HepG2.2.15. Mol Biol Rep. 2010;37(5):2235\u20139.","journal-title":"Mol Biol Rep"},{"key":"3313_CR82","doi-asserted-by":"crossref","unstructured":"Lu R, Zhang Y-g, Xia Y, Zhang J, Kaser A, Blumberg R, Sun J. Paneth Cell Alertness to Pathogens Maintained by Vitamin D Receptors. Gastroenterology, 2021, 160(4) 1269\u201383.","DOI":"10.1053\/j.gastro.2020.11.015"},{"issue":"1","key":"3313_CR83","doi-asserted-by":"publisher","first-page":"2202593","DOI":"10.1080\/19490976.2023.2202593","volume":"15","author":"YG Zhang","year":"2023","unstructured":"Zhang YG, Xia Y, Zhang J, Deb S, Garrett S, Sun J. Intestinal vitamin D receptor protects against extraintestinal breast cancer tumorigenesis. Gut Microbes. 2023;15(1):2202593.","journal-title":"Gut Microbes"},{"issue":"4","key":"3313_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000044","volume":"17","author":"Y Sun","year":"2019","unstructured":"Sun Y, Reid B, Ferreira F, Luxardi G, Ma L, Lokken KL, Zhu K, Xu G, Sun Y, et al. Infection-generated electric field in gut epithelium drives bidirectional migration of macrophages. PLoS Biol. 2019;17(4): e3000044.","journal-title":"PLoS Biol"},{"issue":"5","key":"3313_CR85","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.gendis.2020.08.002","volume":"8","author":"J Zhang","year":"2021","unstructured":"Zhang J, Xia Y, Sun J. Breast and gut microbiome in health and cancer. Genes Dis. 2021;8(5):581\u20139.","journal-title":"Genes Dis"},{"issue":"3","key":"3313_CR86","doi-asserted-by":"publisher","first-page":"194","DOI":"10.5223\/pghn.2022.25.3.194","volume":"25","author":"V Notarbartolo","year":"2022","unstructured":"Notarbartolo V, Giuffr\u00e8 M, Montante C, Corsello G, Carta M. Composition of human breast milk microbiota and its role in children\u2019s health. Pediatric Gastroenterol Hepatol Nutr. 2022;25(3):194\u2013210.","journal-title":"Pediatric Gastroenterol Hepatol Nutr"},{"issue":"6","key":"3313_CR87","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.cell.2024.01.040","volume":"187","author":"S Peng","year":"2024","unstructured":"Peng S, Li JJ, Song W, Li Y, Zeng L, Liang Q, et al. CRB1-associated retinal degeneration is dependent on bacterial translocation from the gut. Cell. 2024;187(6):1387\u2013401.","journal-title":"Cell"},{"key":"3313_CR88","doi-asserted-by":"crossref","unstructured":"Peng HR, Qiu JQ, Zhou QM, Zhang YK, Chen QY, Yin YQ, Su W, Yu S, Wang YT, et al. Intestinal epithelial dopamine receptor signaling drives sex-specific disease exacerbation in a mouse model of multiple sclerosis. Immunity. 2023;56(12):2773\u201389e8.","DOI":"10.1016\/j.immuni.2023.10.016"},{"issue":"1","key":"3313_CR89","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12876-022-02100-8","volume":"22","author":"Y Ding","year":"2022","unstructured":"Ding Y, Wang K, Xu C, Hao M, Li H, Ding L. Intestinal Claudin-7 deficiency impacts the intestinal microbiota in mice with colitis. BMC Gastroenterol. 2022;22(1):24.","journal-title":"BMC Gastroenterol"},{"key":"3313_CR90","doi-asserted-by":"crossref","unstructured":"Coutry N, Gasmi I, Herbert F, Jay P. Mechanisms of intestinal dysbiosis: new insights into tuft cell functions. Gut Microbes, 2024;16(1):2379624.","DOI":"10.1080\/19490976.2024.2379624"},{"issue":"1","key":"3313_CR91","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ccell.2023.12.006","volume":"42","author":"V Chandra","year":"2024","unstructured":"Chandra V, Li L, Le Roux O, Zhang Y, Howell RM, Rupani DN, Baydogan S, Miller HD, Riquelme E, et al. Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation. Cancer Cell. 2024;42(1):85\u2013100.e6.","journal-title":"Cancer Cell"},{"issue":"2","key":"3313_CR92","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/ijms20020395","volume":"20","author":"I Milosevic","year":"2019","unstructured":"Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A, et al. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature. Int J Mol Sci. 2019;20(2):395.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3313_CR93","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2020;72(3):558\u201377.","journal-title":"J Hepatol"},{"issue":"11","key":"3313_CR94","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1111\/cas.15142","volume":"112","author":"N Ohtani","year":"2021","unstructured":"Ohtani N, Hara E. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota. Cancer Sci. 2021;112(11):4433\u201343.","journal-title":"Cancer Sci"},{"issue":"1","key":"3313_CR95","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.hbpd.2018.11.002","volume":"18","author":"J-W Jiang","year":"2019","unstructured":"Jiang J-W, Chen X-H, Ren Z, Zheng S-S. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis. Hepatobiliary Pancreat Dis Int. 2019;18(1):19\u201327.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"7","key":"3313_CR96","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","volume":"15","author":"A Tripathi","year":"2018","unstructured":"Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15(7):397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3313_CR97","doi-asserted-by":"crossref","unstructured":"Guan H, Zhang X, Kuang M, Yu J. The gut\u2013liver axis in immune remodeling of hepatic cirrhosis. Front Immunol. 2022;13:946628.","DOI":"10.3389\/fimmu.2022.946628"},{"issue":"5","key":"3313_CR98","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1099\/ijs.0.02873-0","volume":"54","author":"M Derrien","year":"2004","unstructured":"Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54(5):1469\u201376.","journal-title":"Int J Syst Evol Microbiol."},{"key":"3313_CR99","doi-asserted-by":"crossref","unstructured":"Cao S, Miao J, Qian M, Zhu C, Ding S, Yin J, et al. Helicobacter hepaticus infection promotes the progression of liver preneoplasia in BALB\/c mice via the activation and accumulation of high-mobility group box-1. Front Microbiol. 2022;12:789752.","DOI":"10.3389\/fmicb.2021.789752"},{"issue":"21","key":"3313_CR100","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.3390\/ijms20215314","volume":"20","author":"B Khambu","year":"2019","unstructured":"Khambu B, Yan S, Huda N, Yin X-M. Role of high-mobility group box-1 in liver pathogenesis. Int J Mole Sci. 2019;20(21):5314.","journal-title":"Int J Mole Sci"},{"key":"3313_CR101","doi-asserted-by":"crossref","unstructured":"Xu W, Jiang Y, Tao J, Liu Y, Xia Y, Chen C, et al. Correlation analysis for alterations of intestinal flora in hepatocellular carcinoma patients: combinatorial detection of Coriobacterium, Atopobium, Coprococcus and Veillonella dispar may be a new method for HCC diagnosis. J Med Microbiol. 2023;72(6):001713.","DOI":"10.1099\/jmm.0.001713"},{"issue":"1","key":"3313_CR102","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00253-023-12845-1","volume":"108","author":"T Jinato","year":"2024","unstructured":"Jinato T, Anuntakarun S, Satthawiwat N, Chuaypen N, Tangkijvanich P. Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma. Appl Microbiol Biotechnol. 2024;108(1):34.","journal-title":"Appl Microbiol Biotechnol"},{"key":"3313_CR103","doi-asserted-by":"crossref","unstructured":"Zhang H, Li C, Han L, Xiao Y, Bian J, Liu C, et al. MUP1 mediates urolithin A alleviation of chronic alcohol-related liver disease via gut-microbiota-liver axis. Gut Microbes. 2024;16(1):2367342.","DOI":"10.1080\/19490976.2024.2367342"},{"issue":"4","key":"3313_CR104","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","volume":"70","author":"X Zhang","year":"2021","unstructured":"Zhang X, Coker OO, Chu ESH, Fu K, Lau HCH, Wang Y-X, Chan AWH, Wei H, Yang X, et al. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut. 2021;70(4):761\u201374.","journal-title":"Gut"},{"issue":"7456","key":"3313_CR105","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499(7456):97\u2013101.","journal-title":"Nature"},{"issue":"5","key":"3313_CR106","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","volume":"7","author":"TM Loo","year":"2017","unstructured":"Loo TM, Kamachi F, Watanabe Y, Yoshimoto S, Kanda H, Arai Y, Nakajima-Takagi Y, Iwama A, Koga T, et al. Gut microbiota promotes obesity-associated liver cancer through PGE(2)-mediated suppression of antitumor immunity. Cancer Discov. 2017;7(5):522\u201338.","journal-title":"Cancer Discov"},{"issue":"1","key":"3313_CR107","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","volume":"12","author":"J Behary","year":"2021","unstructured":"Behary J, Amorim N, Jiang XT, Raposo A, Gong L, McGovern E, Ibrahim R, Chu F, Stephens C, et al. Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. Nat Commun. 2021;12(1):187.","journal-title":"Nat Commun"},{"issue":"4","key":"3313_CR108","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/cmi.2010.5","volume":"7","author":"F Lafdil","year":"2010","unstructured":"Lafdil F, Miller AM, Ki SH, Gao B. Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol. 2010;7(4):250\u20134.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"3313_CR109","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jhep.2019.12.016","volume":"72","author":"HY Ma","year":"2020","unstructured":"Ma HY, Yamamoto G, Xu J, Liu X, Karin D, Kim JY, Alexandrov LB, Koyama Y, Nishio T, et al. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease. J Hepatol. 2020;72(5):946\u201359.","journal-title":"J Hepatol"},{"issue":"3","key":"3313_CR110","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139(3):485\u201398.","journal-title":"Cell"},{"issue":"4","key":"3313_CR111","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2024.01.001","volume":"187","author":"G Kim","year":"2024","unstructured":"Kim G, Chen Z, Li J, Luo J, Castro-Martinez F, Wisniewski J, Cui K, Wang Y, Sun J, et al. Gut-liver axis calibrates intestinal stem cell fitness. Cell. 2024;187(4):914\u201330.e20.","journal-title":"Cell"},{"issue":"5","key":"3313_CR112","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1158\/2159-8290.CD-20-0537","volume":"11","author":"S Parida","year":"2021","unstructured":"Parida S, Wu S, Siddharth S, Wang G, Muniraj N, Nagalingam A, Hum C, Mistriotis P, Hao H, et al. A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and beta-catenin axes. Cancer Discov. 2021;11(5):1138\u201357.","journal-title":"Cancer Discov"},{"issue":"1","key":"3313_CR113","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1186\/s12885-024-12721-9","volume":"24","author":"W Lin","year":"2024","unstructured":"Lin W, Gu C, Chen Z, Xue S, Wu H, Zeng L. Exploring the relationship between gut microbiota and breast cancer risk in European and East Asian populations using Mendelian randomization. BMC Cancer. 2024;24(1):970.","journal-title":"BMC Cancer"},{"issue":"1","key":"3313_CR114","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mrrev.2010.03.001","volume":"705","author":"AM Westbrook","year":"2010","unstructured":"Westbrook AM, Szakmary A, Schiestl RH. Mechanisms of intestinal inflammation and development of associated cancers: Lessons learned from mouse models. Mutation Res Rev Mutation Res. 2010;705(1):40\u201359.","journal-title":"Mutation Res Rev Mutation Res"},{"issue":"15","key":"3313_CR115","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1158\/0008-5472.CAN-06-0558","volume":"66","author":"VP Rao","year":"2006","unstructured":"Rao VP, Poutahidis T, Ge Z, Nambiar PR, Boussahmain C, Wang YY, Horwitz BH, Fox JG, Erdman SE. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res. 2006;66(15):7395\u2013400.","journal-title":"Cancer Res"},{"issue":"1","key":"3313_CR116","doi-asserted-by":"publisher","first-page":"2057399","DOI":"10.1080\/2162402X.2022.2057399","volume":"11","author":"H Deng","year":"2022","unstructured":"Deng H, Muthupalani S, Erdman S, Liu H, Niu Z, Wang TC, Fox JG. Translocation of Helicobacter hepaticus synergizes with myeloid-derived suppressor cells and contributes to breast carcinogenesis. Oncoimmunology. 2022;11(1):2057399.","journal-title":"Oncoimmunology"},{"key":"3313_CR117","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejca.2021.11.006","volume":"161","author":"Z Juan","year":"2022","unstructured":"Juan Z, Chen J, Ding B, Yongping L, Liu K, Wang L, et al. Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial. Eur J Cancer. 2022;161:10\u201322.","journal-title":"Eur J Cancer"},{"key":"3313_CR118","doi-asserted-by":"crossref","unstructured":"Tirgar A, Rezaei M, Ehsani M, Salmani Z, Rastegari A, Jafari E, et al. Exploring the synergistic effects of vitamin D and synbiotics on cytokines profile, and treatment response in breast cancer: a pilot randomized clinical trial. Sci Rep. 2024;14(1):21372.","DOI":"10.1038\/s41598-024-72172-x"},{"issue":"1","key":"3313_CR119","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1479-5876-10-253","volume":"10","author":"R Flores","year":"2012","unstructured":"Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, Gajer P, Ravel J, Goedert JJ. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med. 2012;10(1):253.","journal-title":"J Transl Med"},{"issue":"4","key":"3313_CR120","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.chom.2011.10.003","volume":"10","author":"CS Plottel","year":"2011","unstructured":"Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host Microbe. 2011;10(4):324\u201335.","journal-title":"Cell Host Microbe"},{"issue":"5","key":"3313_CR121","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/cells9051091","volume":"9","author":"S Parida","year":"2020","unstructured":"Parida S, Sharma D. Microbial alterations and risk factors of breast cancer: connections and mechanistic insights. Cells. 2020;9(5):1091.","journal-title":"Cells"},{"issue":"8","key":"3313_CR122","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/ijerph15081747","volume":"15","author":"MF Fernandez","year":"2018","unstructured":"Fernandez MF, Reina-Perez I, Astorga JM, Rodriguez-Carrillo A, Plaza-Diaz J, Fontana L. Breast cancer and its relationship with the microbiota. Int J Environ Res Public Health. 2018;15(8):1747.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"3313_CR123","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/bjc.2017.435","volume":"118","author":"JJ Goedert","year":"2018","unstructured":"Goedert JJ, Hua X, Bielecka A, Okayasu I, Milne GL, Jones GS, Fujiwara M, Sinha R, Wan Y, et al. Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota. Br J Cancer. 2018;118(4):471\u20139.","journal-title":"Br J Cancer"},{"key":"3313_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-024-01443-4","author":"G Dohrn","year":"2024","unstructured":"Dohrn G. Gut microbes linked to fatty diet drive tumour growth. Nature. 2024. https:\/\/doi.org\/10.1038\/d41586-024-01443-4.","journal-title":"Nature"},{"issue":"20","key":"3313_CR125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2306776121","volume":"121","author":"J Chen","year":"2024","unstructured":"Chen J, Liu X, Zou Y, Gong J, Ge Z, Lin X, Zhang W, Huang H, Zhao J, et al. A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation. Proc Natl Acad Sci USA. 2024;121(20): e2306776121.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"40","key":"3313_CR126","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.3748\/wjg.v19.i40.6794","volume":"19","author":"H Wang","year":"2013","unstructured":"Wang H, Liu JS, Peng SH, Deng XY, Zhu DM, Javidiparsijani S, Wang GR, Li DQ, Li LX, et al. Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases. World J Gastroenterol. 2013;19(40):6794\u2013804.","journal-title":"World J Gastroenterol"},{"issue":"30","key":"3313_CR127","doi-asserted-by":"publisher","first-page":"49574","DOI":"10.18632\/oncotarget.17319","volume":"8","author":"YJ Zhou","year":"2017","unstructured":"Zhou YJ, Zhao DD, Liu H, Chen HT, Li JJ, Mu XQ, Liu Z, Li X, Tang L, et al. Cancer killers in the human gut microbiota: diverse phylogeny and broad spectra. Oncotarget. 2017;8(30):49574\u201391.","journal-title":"Oncotarget"},{"key":"3313_CR128","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fcimb.2019.00112","volume":"9","author":"H Zhuang","year":"2019","unstructured":"Zhuang H, Cheng L, Wang Y, Zhang YK, Zhao MF, Liang GD, et al. Dysbiosis of the gut microbiome in lung cancer. Front Cell Infect Microbiol. 2019;9:112.","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"3313_CR129","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s00432-021-03644-0","volume":"147","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Liu Y, Li S, Peng Z, Liu X, Chen J, Zheng X. Role of lung and gut microbiota on lung cancer pathogenesis. J Cancer Res Clin Oncol. 2021;147(8):2177\u201386.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"19","key":"3313_CR130","doi-asserted-by":"publisher","first-page":"10429","DOI":"10.3390\/ijms221910429","volume":"22","author":"K Georgiou","year":"2021","unstructured":"Georgiou K, Marinov B, Farooqi AA, Gazouli M. Gut microbiota in lung cancer: Where do we stand? Int J Mol Sci. 2021;22(19):10429.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3313_CR131","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12950-024-00427-5","volume":"21","author":"YJ Li","year":"2024","unstructured":"Li YJ, Geng W-L, Li C-C, Wu J-H, Gao F, Wang Y. Progress of CCL20-CCR6 in the airways: a promising new therapeutic target. J Inflamm. 2024;21(1):54.","journal-title":"J Inflamm"},{"key":"3313_CR132","doi-asserted-by":"crossref","unstructured":"Correa RO, Castro PR, Moser R, Ferreira CM, Quesniaux VFJ, Vinolo MAR, et al. Butyrate: connecting the gut-lung axis to the management of pulmonary disorders. Front Nutr. 2022;9:1011732.","DOI":"10.3389\/fnut.2022.1011732"},{"issue":"4","key":"3313_CR133","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41385-019-0160-6","volume":"12","author":"AT Dang","year":"2019","unstructured":"Dang AT, Marsland BJ. Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. 2019;12(4):843\u201350.","journal-title":"Mucosal Immunol"},{"key":"3313_CR134","doi-asserted-by":"crossref","unstructured":"Chen Z, Wang Z, Ma H, Bao H, Jiang T, Yang T, et al. Immune cells mediated the causal relationship between the gut microbiota and lung cancer: a Mendelian randomization study. Front Microbiol. 2024;15:1390722.","DOI":"10.3389\/fmicb.2024.1390722"},{"issue":"12","key":"3313_CR135","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1158\/0008-5472.CAN-20-3564","volume":"81","author":"R Li","year":"2021","unstructured":"Li R, Salehi-Rad R, Crosson W, Momcilovic M, Lim RJ, Ong SL, Huang ZL, Zhang T, Abascal J, et al. Inhibition of granulocytic myeloid-derived suppressor cells overcomes resistance to immune checkpoint inhibition in LKB1-deficient non-small cell lung cancer. Can Res. 2021;81(12):3295\u2013308.","journal-title":"Can Res"},{"issue":"4","key":"3313_CR136","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","volume":"19","author":"DB Johnson","year":"2022","unstructured":"Johnson DB, Nebhan CA, Moslehi JJ, Balko JM. Immune-checkpoint inhibitors: long-term implications of toxicity. Nat Rev Clin Oncol. 2022;19(4):254\u201367.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"3313_CR137","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-20-0051","volume":"8","author":"Y Tomita","year":"2020","unstructured":"Tomita Y, Ikeda T, Sakata S, Saruwatari K, Sato R, Iyama S, Jodai T, Akaike K, Ishizuka S, et al. Association of probiotic clostridium butyricum therapy with survival and response to immune checkpoint blockade in patients with lung cancer. Cancer Immunol Res. 2020;8(10):1236\u201342.","journal-title":"Cancer Immunol Res"},{"key":"3313_CR138","doi-asserted-by":"crossref","unstructured":"Tsay J-CJ, Wu BG, Badri MH, Clemente JC, Shen N, Meyn P, Li Y, Yie T-A, Lhakhang T, et al. Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med. 2018;198(9):1188\u201398.","DOI":"10.1164\/rccm.201710-2118OC"},{"issue":"12","key":"3313_CR139","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1158\/2326-6066.CIR-24-0469","volume":"12","author":"Z Rahal","year":"2024","unstructured":"Rahal Z, Liu Y, Peng F, Yang S, Jamal MA, Sharma M, Moreno H, Damania AV, Wong MC, et al. Inflammation mediated by gut microbiome alterations promotes lung cancer development and an immunosuppressed tumor microenvironment. Cancer Immunol Res. 2024;12(12):1736\u201352.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"3313_CR140","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.chom.2016.03.007","volume":"19","author":"R Moschen Alexander","year":"2016","unstructured":"Moschen Alexander R, Gerner Romana R, Wang J, Klepsch V, Adolph Timon E, Reider Simon J, Hackl H, Pfister A, Schilling J, et al. Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations. Cell Host Microbe. 2016;19(4):455\u201369.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"3313_CR141","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234\u201348.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3313_CR142","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/microorganisms11010107","volume":"11","author":"N Nikolaieva","year":"2022","unstructured":"Nikolaieva N, Sevcikova A, Omelka R, Martiniakova M, Mego M, Ciernikova S. Gut microbiota-MicroRNA interactions in intestinal homeostasis and cancer development. Microorganisms. 2022;11(1):107.","journal-title":"Microorganisms"},{"issue":"1","key":"3313_CR143","doi-asserted-by":"publisher","first-page":"1788891","DOI":"10.1080\/19490976.2020.1788891","volume":"12","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Huang J, Li X, Xing J, Chen Q, Liu R, Hua F, Qiu Z, Song Y, et al. Gut microbiota regulate tumor metastasis via circRNA\/miRNA networks. Gut Microbes. 2020;12(1):1788891.","journal-title":"Gut Microbes"},{"issue":"1","key":"3313_CR144","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-020-01648-1","volume":"39","author":"W Hong","year":"2020","unstructured":"Hong W, Xue M, Jiang J, Zhang Y, Gao X. Circular RNA circ-CPA4\/ let-7 miRNA\/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC). J Exp Clin Cancer Res. 2020;39(1):149.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"3313_CR145","doi-asserted-by":"publisher","first-page":"19019","DOI":"10.1002\/jcb.29225","volume":"120","author":"Y Chi","year":"2019","unstructured":"Chi Y, Luo Q, Song Y, Yang F, Wang Y, Jin M, Zhang D. Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600\/HIF-1alpha regulation. J Cell Biochem. 2019;120(11):19019\u201330.","journal-title":"J Cell Biochem"},{"issue":"7","key":"3313_CR146","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18(7):493\u2013502.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3313_CR147","doi-asserted-by":"crossref","unstructured":"Li Q, Jin M, Liu Y, Jin L. Gut microbiota: its potential roles in pancreatic Cancer. Front Cell Infect Microbiol. 2020;10:572492.","DOI":"10.3389\/fcimb.2020.572492"},{"issue":"1","key":"3313_CR148","doi-asserted-by":"publisher","first-page":"20319","DOI":"10.1038\/s41598-020-77322-5","volume":"10","author":"S-M Chen","year":"2020","unstructured":"Chen S-M, Chieng W-W, Huang S-W, Hsu L-J, Jan M-S. The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine. Sci Rep. 2020;10(1):20319.","journal-title":"Sci Rep"},{"issue":"12","key":"3313_CR149","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.3390\/nu13124425","volume":"13","author":"BK Sobocki","year":"2021","unstructured":"Sobocki BK, Kazmierczak-Siedlecka K, Folwarski M, Hawrylkowicz V, Makarewicz W, Stachowska E. Pancreatic cancer and gut microbiome-related aspects: a comprehensive review and dietary recommendations. Nutrients. 2021;13(12):4425.","journal-title":"Nutrients"},{"issue":"4","key":"3313_CR150","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, Mohan N, Aykut B, Usyk M, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8(4):403\u201316.","journal-title":"Cancer Discov"},{"issue":"12","key":"3313_CR151","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1084\/jem.20142162","volume":"212","author":"CP Zambirinis","year":"2015","unstructured":"Zambirinis CP, Levie E, Nguy S, Avanzi A, Barilla R, Xu Y, Seifert L, Daley D, Greco SH, et al. TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. J Exp Med. 2015;212(12):2077\u201394.","journal-title":"J Exp Med"},{"issue":"Pt 2","key":"3313_CR152","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1099\/jmm.0.064220-0","volume":"63","author":"R Kant","year":"2014","unstructured":"Kant R, de Vos WM, Palva A, Satokari R. Immunostimulatory CpG motifs in the genomes of gut bacteria and their role in human health and disease. J Med Microbiol. 2014;63(Pt 2):293\u2013308.","journal-title":"J Med Microbiol"},{"issue":"1","key":"3313_CR153","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1038\/s41467-024-51534-z","volume":"15","author":"Z-Y Han","year":"2024","unstructured":"Han Z-Y, Fu Z-J, Wang Y-Z, Zhang C, Chen Q-W, An J-X, et al. Probiotics functionalized with a gallium-polyphenol network modulate the intratumor microbiota and promote anti-tumor immune responses in pancreatic cancer. Nat Commun. 2024;15(1):7096.","journal-title":"Nat Commun"},{"issue":"5","key":"3313_CR154","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/cancers12051326","volume":"12","author":"K Kazmierczak-Siedlecka","year":"2020","unstructured":"Kazmierczak-Siedlecka K, Dvorak A, Folwarski M, Daca A, Przewlocka K, Makarewicz W. Fungal gut microbiota dysbiosis and its role in colorectal, oral, and pancreatic carcinogenesis. Cancers (Basel). 2020;12(5):1326.","journal-title":"Cancers (Basel)"},{"issue":"7777","key":"3313_CR155","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","volume":"574","author":"B Aykut","year":"2019","unstructured":"Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim JI, Shadaloey SA, Wu D, Preiss P, et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 2019;574(7777):264\u20137.","journal-title":"Nature"},{"key":"3313_CR156","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fcimb.2020.00201","volume":"10","author":"M Spatz","year":"2020","unstructured":"Spatz M, Richard ML. Overview of the potential role of Malassezia in gut health and disease. Front Cell Infect Microbiol. 2020;10:201.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"3313_CR157","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1172\/JCI90962","volume":"127","author":"V Afshar-Kharghan","year":"2017","unstructured":"Afshar-Kharghan V. The role of the complement system in cancer. J Clin Investig. 2017;127(3):780\u20139.","journal-title":"J Clin Investig"},{"key":"3313_CR158","doi-asserted-by":"crossref","unstructured":"Xie Y, Xie F, Zhou X, Zhang L, Yang B, Huang J, et al. Microbiota in tumors: from understanding to application. Adv Sci. 2022;9(21):e2200470.","DOI":"10.1002\/advs.202200470"},{"issue":"9","key":"3313_CR159","doi-asserted-by":"publisher","first-page":"6675","DOI":"10.1007\/s00432-023-04576-7","volume":"149","author":"Y Gong","year":"2023","unstructured":"Gong Y, Huang X, Wang M, Liang X. Intratumor microbiota: a novel tumor component. J Cancer Res Clin Oncol. 2023;149(9):6675\u201391.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"3313_CR160","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","volume":"8","author":"L Yang","year":"2023","unstructured":"Yang L, Li A, Wang Y, Zhang Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Trans Target Ther. 2023;8(1):35.","journal-title":"Signal Trans Target Ther"},{"issue":"8","key":"3313_CR161","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"A Fu","year":"2022","unstructured":"Fu A, Yao B, Dong T, Chen Y, Yao J, Liu Y, Li H, Bai H, Liu X, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185(8):1356\u201372.e26.","journal-title":"Cell"},{"key":"3313_CR162","doi-asserted-by":"crossref","unstructured":"Li S, Li Q, Lu W. Intratumoral microbiome and gastrointestinal cancers. Front Oncol. 2022;12:1047015.","DOI":"10.3389\/fonc.2022.1047015"},{"issue":"2","key":"3313_CR163","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2018.11.003","volume":"27","author":"R Eisenhofer","year":"2019","unstructured":"Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R, Weyrich LS. Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol. 2019;27(2):105\u201317.","journal-title":"Trends Microbiol"},{"issue":"7972","key":"3313_CR164","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/s41586-023-06292-1","volume":"620","author":"AA Fletcher","year":"2023","unstructured":"Fletcher AA, Kelly MS, Eckhoff AM, Allen PJ. Revisiting the intrinsic mycobiome in pancreatic cancer. Nature. 2023;620(7972):E1\u20136.","journal-title":"Nature"},{"key":"3313_CR165","doi-asserted-by":"crossref","unstructured":"Gihawi A, Cooper CS, Brewer DS. Caution regarding the specificities of pan-cancer microbial structure. Microbial Genom. 2023;9(8):mgen001088.","DOI":"10.1099\/mgen.0.001088"},{"key":"3313_CR166","doi-asserted-by":"crossref","unstructured":"Gihawi A, Ge Y, Lu J, Puiu D, Xu A, Cooper CS, et al. Major data analysis errors invalidate cancer microbiome findings. mBio. 2023;14(5):e01607\u201323.","DOI":"10.1128\/mbio.01607-23"},{"issue":"4","key":"3313_CR167","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178(4):795\u2013806.e12.","journal-title":"Cell"},{"issue":"22","key":"3313_CR168","doi-asserted-by":"publisher","first-page":"e200e","DOI":"10.1093\/nar\/gkq873","volume":"38","author":"MJ Claesson","year":"2010","unstructured":"Claesson MJ, Wang Q, O\u2019Sullivan O, Greene-Diniz R, Cole JR, Ross RP, O\u2019Toole PW. Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res. 2010;38(22):e200e.","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"3313_CR169","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12864-024-10213-5","volume":"25","author":"E Buetas","year":"2024","unstructured":"Buetas E, Jord\u00e1n-L\u00f3pez M, L\u00f3pez-Rold\u00e1n A, D\u2019Auria G, Mart\u00ednez-Priego L, De Marco G, et al. Full-length 16S rRNA gene sequencing by PacBio improves taxonomic resolution in human microbiome samples. BMC Genomics. 2024;25(1):310.","journal-title":"BMC Genomics"},{"issue":"2","key":"3313_CR170","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1586\/14737159.5.2.209","volume":"5","author":"M Arya","year":"2014","unstructured":"Arya M, Shergill IS, Williamson M, Gommersall L, Arya N, Patel HRH. Basic principles of real-time quantitative PCR. Expert Rev Mol Diagn. 2014;5(2):209\u201319.","journal-title":"Expert Rev Mol Diagn"},{"issue":"9","key":"3313_CR171","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1001\/jamaoncol.2022.2810","volume":"8","author":"H Qiao","year":"2022","unstructured":"Qiao H, Tan X-R, Li H, Li J-Y, Chen X-Z, Li Y-Q, et al. Association of intratumoral microbiota with prognosis in patients with nasopharyngeal carcinoma from 2 hospitals in China. JAMA Oncol. 2022;8(9):1301\u20139.","journal-title":"JAMA Oncol"},{"key":"3313_CR172","doi-asserted-by":"crossref","unstructured":"Hou Y, Chen S, Zheng Y, Zheng X, Lin J-M. Droplet-based digital PCR (ddPCR) and its applications. TrAC Trends Anal Chem. 2023;158:116897.","DOI":"10.1016\/j.trac.2022.116897"},{"issue":"1","key":"3313_CR173","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13059-021-02401-3","volume":"22","author":"E Zozaya-Vald\u00e9s","year":"2021","unstructured":"Zozaya-Vald\u00e9s E, Wong SQ, Raleigh J, Hatzimihalis A, Ftouni S, Papenfuss AT, et al. Detection of cell-free microbial DNA using a contaminant-controlled analysis framework. Genome Biol. 2021;22(1):187.","journal-title":"Genome Biol"},{"issue":"11","key":"3313_CR174","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1038\/s41596-023-00888-7","volume":"18","author":"JL Galeano Ni\u00f1o","year":"2023","unstructured":"Galeano Ni\u00f1o JL, Wu H, LaCourse KD, Srinivasan H, Fitzgibbon M, Minot SS, Sather C, Johnston CD, Bullman S. INVADEseq to identify cell-adherent or invasive bacteria and the associated host transcriptome at single-cell-level resolution. Nat Protoc. 2023;18(11):3355\u201389.","journal-title":"Nat Protoc"},{"issue":"7937","key":"3313_CR175","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, Futran N, Houlton J, Sather C, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022;611(7937):810\u20137.","journal-title":"Nature"},{"key":"3313_CR176","doi-asserted-by":"crossref","unstructured":"Jiang H, Cao Z, Liu Y, Liu R, Zhou Y, Liu J. Bacteria\u2010based living probes: preparation and the applications in bioimaging and diagnosis. Adv Sci. 2023;11(4):e2306480.","DOI":"10.1002\/advs.202306480"},{"issue":"4","key":"3313_CR177","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00259-019-04639-3","volume":"47","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang C, Lai J, Zhao Y, Lu D, Bao R, Feng X, Zhang T, Liu Z. Noninvasive PET tracking of post-transplant gut microbiota in living mice. Eur J Nucl Med Mol Imaging. 2020;47(4):991\u20131002.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3313_CR178","doi-asserted-by":"crossref","unstructured":"Chen D, Guo J, Li A, Sun C, Lin H, Lin H, et al. Metabolic fluorine labeling and hotspot imaging of dynamic gut microbiota in mice. Sci Adv. 2023;9(4):eabg6808.","DOI":"10.1126\/sciadv.abg6808"},{"issue":"7","key":"3313_CR179","doi-asserted-by":"publisher","first-page":"6886","DOI":"10.1021\/acsnano.3c00600","volume":"17","author":"C Zhang","year":"2023","unstructured":"Zhang C, Gao X, Ren X, Xu T, Peng Q, Zhang Y, Chao Z, Jiang W, Jia L, et al. Bacteria-induced colloidal encapsulation for probiotic oral delivery. ACS Nano. 2023;17(7):6886\u201398.","journal-title":"ACS Nano"},{"issue":"1","key":"3313_CR180","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40168-018-0485-5","volume":"6","author":"M Bilen","year":"2018","unstructured":"Bilen M, Dufour J-C, Lagier J-C, Cadoret F, Daoud Z, Dubourg G, et al. The contribution of culturomics to the repertoire of isolated human bacterial and archaeal species. Microbiome. 2018;6(1):94.","journal-title":"Microbiome"},{"issue":"9","key":"3313_CR181","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41579-018-0041-0","volume":"16","author":"J-C Lagier","year":"2018","unstructured":"Lagier J-C, Dubourg G, Million M, Cadoret F, Bilen M, Fenollar F, Levasseur A, Rolain J-M, Fournier P-E, et al. Culturing the human microbiota and culturomics. Nat Rev Microbiol. 2018;16(9):540\u201350.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"3313_CR182","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.tibtech.2021.08.007","volume":"40","author":"MV Monteiro","year":"2022","unstructured":"Monteiro MV, Zhang YS, Gaspar VM, Mano JF. 3D-bioprinted cancer-on-a-chip: level-up organotypic in vitro models. Trends Biotechnol. 2022;40(4):432\u201347.","journal-title":"Trends Biotechnol"},{"key":"3313_CR183","doi-asserted-by":"crossref","unstructured":"Augustine R, Kalva SN, Ahmad R, Zahid AA, Hasan S, Nayeem A, et al. 3D Bioprinted cancer models: revolutionizing personalized cancer therapy. Transl Oncol. 2021;14(4):101015.","DOI":"10.1016\/j.tranon.2021.101015"},{"issue":"15","key":"3313_CR184","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41388-024-02974-w","volume":"43","author":"GD Sepich-Poore","year":"2024","unstructured":"Sepich-Poore GD, McDonald D, Kopylova E, Guccione C, Zhu Q, Austin G, Carpenter C, Fraraccio S, Wandro S, et al. Robustness of cancer microbiome signals over a broad range of methodological variation. Oncogene. 2024;43(15):1127\u201348.","journal-title":"Oncogene"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03313-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03313-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03313-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T03:04:38Z","timestamp":1738897478000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03313-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":184,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3313"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03313-x","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}